Antidepressants in clinical practice: Limitations of assessment methods and drug response

被引:35
|
作者
Kennedy, SH [1 ]
Eisfeld, BS [1 ]
Meyer, JH [1 ]
Bagby, RM [1 ]
机构
[1] Univ Toronto, Ctr Addict & Mental Hlth, Toronto, ON M5T 1RB, Canada
关键词
antidepressants; efficacy; diagnostic heterogeneity functional brain imaging; Major Depressive Disorder;
D O I
10.1002/hup.189
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
There is a recognized gap between knowledge derived from 'efficacy' data - based on usually brief randomized controlled trials and findings in natural practice 'effectiveness' studies. In considering the limitations of current antidepressants in clinical practice, we have selected three clinically important issues to examine in a natural practice data base that has been in existence for several years. These relate to: (I) Diagnostic heterogeneity and potential advances using functional brain imaging; (2) Variability of outcome measures during treatment and (3) Time to response and prediction of outcome. Copyright (C) 2001 John Wiley & Sons, Ltd.
引用
收藏
页码:105 / 114
页数:10
相关论文
共 50 条
  • [1] Therapeutic drug monitoring of tricyclic antidepressants in everyday clinical practice
    Pfuhlmann, B.
    Gerlach, M.
    Burger, R.
    Gonska, S.
    Unterecker, S.
    Jabs, B.
    Riederer, P.
    Deckert, J.
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 2007, (72): : 287 - 296
  • [2] Prediction of clinical response to antidepressants in patients with depression: Neurophysiology in clinical practice
    Pogarell, Oliver
    Juckel, Georg
    Norra, Christine
    Leicht, Gregor
    Karch, Susanne
    Schaaff, Nadine
    Folkerts, Malte
    Ibrahim, Ahmad
    Mulert, Christoph
    Hegerl, Ulrich
    CLINICAL EEG AND NEUROSCIENCE, 2007, 38 (02) : 74 - 77
  • [3] Chromatographic methods development for clinical practice: requirements and limitations
    Krcmova, Lenka Kujovska
    Melichar, Bohuslav
    Svec, Frantisek
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2020, 58 (11) : 1785 - 1793
  • [4] Therapeutic drug monitoring of antidepressants - Cost implications and relevance to clinical practice
    Burke, MJ
    Preskorn, SH
    CLINICAL PHARMACOKINETICS, 1999, 37 (02) : 147 - 165
  • [5] Resolving the onset of antidepressants' clinical actions - Critical for clinical practice and new drug development
    Katz, Martin M.
    Bowden, Charles L.
    Berman, Nancy
    Frazer, Alan
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2006, 26 (06) : 549 - 553
  • [6] USE OF ANTIDEPRESSANTS IN CLINICAL PRACTICE
    KLERMAN, GL
    HIRSCHFELD, RMA
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1978, 240 (13): : 1403 - 1406
  • [7] ANTIDEPRESSANTS IN USE IN CLINICAL PRACTICE
    Agius, Mark
    Bonnici, Hannah
    PSYCHIATRIA DANUBINA, 2017, 29 : S667 - S671
  • [8] Propensity score methods in drug safety studies: practice, strengths and limitations
    Wang, JX
    Donnan, PT
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2001, 10 (04) : 341 - 344
  • [9] Prediction of Drug Response and Safety in Clinical Practice
    Monte, Andrew A.
    Heard, Kennon J.
    Vasiliou, Vasilis
    JOURNAL OF MEDICAL TOXICOLOGY, 2012, 8 (01) : 43 - 51
  • [10] Body composition assessment methods in clinical practice
    Leel-Ossy, Tamas
    Babity, Mate
    Zamodics, Mark
    Szigeti, Eszter
    Hajer, Andrea
    Kiss, Orsolya
    Horvath, Csaba
    Meszaros, Szilvia
    ORVOSI HETILAP, 2025, 166 (04) : 130 - 138